Structural Basis of Adomet-Dependent Aminocarboxypropyl Transfer Reaction Catalyzed by Trna-Wybutosine Synthesizing Enzyme, TYW2

Total Page:16

File Type:pdf, Size:1020Kb

Structural Basis of Adomet-Dependent Aminocarboxypropyl Transfer Reaction Catalyzed by Trna-Wybutosine Synthesizing Enzyme, TYW2 Structural basis of AdoMet-dependent aminocarboxypropyl transfer reaction catalyzed by tRNA-wybutosine synthesizing enzyme, TYW2 Masataka Umitsua, Hiroshi Nishimasua, Akiko Nomab, Tsutomu Suzukib, Ryuichiro Ishitania,1, and Osamu Nurekia,1 aDepartment of Basic Medical Sciences, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan; and bDepartment of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan Edited by Paul R. Schimmel, The Scripps Research Institute, La Jolla, CA, and approved July 28, 2009 (received for review May 13, 2009) S-adenosylmethionine (AdoMet) is a methyl donor used by a wide ture (4-demethylwyosine, imG-14), using an adenosyl radical variety of methyltransferases, and it is also used as the source of derived from AdoMet (Fig. 1A) (8). Furthermore, three en- an ␣-amino-␣-carboxypropyl (‘‘acp’’) group by several enzymes. zymes, TYW2, 3, and 4, catalyze AdoMet-dependent modifica- tRNA-yW synthesizing enzyme-2 (TYW2) is involved in the biogen- tions to form the yW nucleoside. In this pathway, TYW2 esis of a hypermodified nucleotide, wybutosine (yW), and it cat- catalyzes the transfer of the ␣-amino-␣-carboxypropyl (acp) alyzes the transfer of the ‘‘acp’’ group from AdoMet to the C7 group, instead of the methyl group, of AdoMet to the C7 position position of the imG-14 base, a yW precursor. This modified nucle- of the tricyclic core structure of imG-14, forming yW-86 (yW oside yW is exclusively located at position 37 of eukaryotic minus 86 Da) (Fig. 1A) (5). A recent study indicated that this acp tRNAPhe, and it ensures the anticodon-codon pairing on the ribo- group of the yW base has a significant negative impact on Ϫ1 somal decoding site. Although this ‘‘acp’’ group has a significant frame shifting at a phenylalanine codon (9), suggesting the role in preventing decoding frame shifts, the mechanism of the biological importance of TYW2 for the maintenance of trans- ‘‘acp’’ group transfer by TYW2 remains unresolved. Here we report lational fidelity. In addition, the enzymes that transfer the acp the crystal structures and functional analyses of two archaeal group of AdoMet to substrates are also present in the biosyn- homologs of TYW2 from Pyrococcus horikoshii and Methanococcus thetic pathways for diphthamide (10), nocardicin (11), and BIOCHEMISTRY jannaschii. The in vitro mass spectrometric and radioisotope-label- diacylglyceryl-O-4Ј-(N,N,N,-trimethyl) homoserine (12). How- ing analyses confirmed that these archaeal TYW2 homologues ever, the detailed mechanism of the acp group transfer by these have the same activity as yeast TYW2. The crystal structures enzymes remains elusive. verified that the archaeal TYW2 contains a canonical class-I meth- Previous studies demonstrated the existence of wyosine (Y) yltransferase (MTase) fold. However, their AdoMet-bound struc- derivatives in several archaea (13–15). Moreover, homologous tures revealed distinctive AdoMet-binding modes, in which the genes to eukaryotic TYW1 and TYW2 exist in archaeal ge- ‘‘acp’’ group, instead of the methyl group, of AdoMet is directed to nomes, suggesting that these Y derivatives are formed by a the substrate binding pocket. Our findings, which were confirmed similar modification pathway to that in eukaryotes. Therefore, by extensive mutagenesis studies, explain why TYW2 transfers the these Y derivatives may play a similar role in maintaining the ‘‘acp’’ group, and not the methyl group, from AdoMet to the translational fidelity of the phenylalanine codon, as in eu- nucleobase. karyotes (15). However, there is no experimental evidence showing that the archaeal Y derivatives are located in the modification ͉ S-adenosylmethionine ͉ X-ray crystallography tRNAPhe anticodon loop. In addition, previous studies reported the archaea-specific Y derivative, 7-methylwyosine (mimG, Fig. ost-transcriptional modifications of RNA molecules have 1A), in which the C7 position is modified by the methyl group, Psignificant biological roles in maintaining life. More than 100 rather than the acp group (13). Thus, the in vivo functions of different modifications exist throughout the three phylogenic these archaeal TYW2 homologues remain elusive. domains (1). Most of these modifications are found in transfer Here, we report the functional characterizations and struc- RNA (tRNA), and they confer various chemical properties to the tural analyses of two archaeal TYW2 enzymes from Pyrococcus RNA residues. Especially, the anticodon loop of tRNA contains horikoshii and Methanococcus jannaschii. An in vitro reconsti- many modified nucleosides, which are considered to facilitate tution assay by mass spectrometry and kinetic analyses with the correct codon-anticodon pairing on the ribosome (2). radioisotope-labeled AdoMet confirmed that the archaeal Wybutosine (yW) is a hypermodified nucleoside located at TYW2 enzymes catalyze the acp group transfer reaction in an position 37, adjacent to the 3Ј position of the anticodon, of AdoMet-dependent manner. The crystal structures of the ar- eukaryotic tRNAPhe. The chemical structure of yW is charac- chaeal TYW2s, in conjunction with the extensive mutational terized by the tricyclic 1H-imidazo[1,2-␣]purine core with a large analyses, provide the structural basis for the transfer of the acp side chain (3) (Fig. 1A). Its bulky, hydrophobic structure is group of AdoMet to the substrate. considered to stabilize not only the conformation of the anti- codon loop itself but also the codon-anticodon pairing on the Ϫ Author contributions: T.S., R.I., and O.N. designed research; M.U., A.N., and R.I. performed ribosome, thereby preventing a potential 1 frame shift at a research; M.U., H.N., A.N., and R.I. analyzed data; and M.U., H.N., A.N., T.S., R.I., and O.N. phenylalanine codon (4). wrote the paper. Recent studies revealed the biosynthetic pathway of yW in The authors declare no conflict of interest. yeast, in which five enzymes catalyze successive S-adenosylme- This article is a PNAS Direct Submission. thionine (AdoMet)-dependent reactions to form yW from the Data deposition: The atomic coordinates and structure factors have been deposited in the G37 residue (5, 6) (Fig. 1A). In the first step, the AdoMet- Protein Data Bank, www.pdb.org (PDB ID codes 3A25, 3A26, and 3A27). 1 dependent tRNA methyltransferase (MTase) Trm5 forms N - 1To whom correspondence may be addressed. E-mail: [email protected] or 1 methylated G37 (m G) (6, 7). In the next step, tRNA-yW [email protected]. synthesizing enzyme-1 (TYW1) catalyzes the radical reaction, This article contains supporting information online at www.pnas.org/cgi/content/full/ involving two [4Fe-4S] clusters, to form the tricyclic ring struc- 0905270106/DCSupplemental. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0905270106 PNAS Early Edition ͉ 1of6 Downloaded by guest on September 25, 2021 Fig. 1. Acp-group transfer catalyzed by PhTYW2. (A) Biosynthetic pathway of wybutosine. The chemical structures of the wyosine derivatives are shown. Modification enzymes, Trm5 and TYW1–4, are involved in each modification step. The chemical groups included in each reaction are shadowed in blue. The chemical structure of AdoMet is shown in the box. The methyl and acp groups are colored green and blue, respectively. (B) In vitro reconstitution of yW-86 Phe synthesis using recombinant PhTYW2. RNaseT1-digested yeast tRNA with the imG-14 intermediate (black), obtained from the ⌬TYW2 strain, was reacted with PhTYW2 in the presence (left panel) or absence (right panel) of AdoMet and was analyzed by LC/MS. Mass chromatographs for anticodon-containing fragments including imG-14 (m/z 661, black), yW-86 (m/z 678, green), and yW-173 (m/z 664, red) are overlaid. (C) Kinetic analysis of the acp-group transfer by PhTYW2. The ␣-carboxyl-14C labeled AdoMet and the imG-14 containing tRNAPhe were incubated at 50 °C with recombinant PhTYW2 (closed circles) and without PhTYW2 (open circles), and the incorporation of ␣-carboxyl-14C into the tRNAPhe was quantified by scintillation counting. Data are represented as mean Ϯ SE (n ϭ 3). Results and Discussion spectrometric analyses, a trace amount of yW-173 (MW 335) was Acp-Group Transfer Activity of Archaeal TYW2. The P. horikoshii detected in all products as well as in the substrate, regardless of PH0793 (278 amino acids) and M. jannashii MJ1557 (249 amino the presence of the enzyme or AdoMet (Fig. 1B and Fig. S1). acids) proteins share 22% and 25% sequence identities to yeast This minor peak may stem from a methylated product of imG-14 TYW2, respectively. To determine whether these archaeal at position N4, formed by endogenous TYW3 in yeast cells. TYW2 homologs possess an activity to transfer the acp group to Altogether, our results indicate that the PH0793 and MJ1557 imG-14 at position 37 of tRNAPhe, we performed in vitro proteins have an activity to form yW-86 from imG-14 at position reconstitution assays using these recombinant proteins (Fig. 1B 37 of tRNAPhe. Therefore, we hereafter refer to PH0793 and and Fig. S1). As a substrate, we used tRNAPhe purified from the MJ1557 as PhTYW2 and MjTYW2, respectively. yeast ⌬TYW2 strain, which contains imG-14 at position 37 (Fig. S1A). In the reconstitution assay with the PH0793 and MJ1557 Structure Determination. To understand the mechanism of the proteins, a mass spectrometric analysis detected AdoMet- modification by TYW2, we determined the crystal structures of dependent products corresponding to yW-86 (Fig. 1B and Fig. S1 PhTYW2 in the AdoMet-bound and 5Ј-deoxy-5Ј-methylthioad- B and D). We confirmed our assignment of the peaks by the enosine (MeSAdo)-bound forms, and MjTYW2 in the AdoMet- positive control experiment with purified yeast TYW2 (Fig. bound form (Fig. 2). The initial phases were obtained by the S1C). To further confirm the activity of the archaeal TYW2 molecular replacement method, using the apo-form PhTYW2 homologs, we assayed the acp-group transfer by monitoring the structure as a search model (PDB ID: 2FRN), which was incorporation of the acp group from ␣-carboxyl-14C labeled previously determined by the structural genomics group as a AdoMet into the imG-14 containing tRNAPhe (Fig.
Recommended publications
  • Us 2018 / 0353618 A1
    US 20180353618A1 ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0353618 A1 Burkhardt et al. (43 ) Pub . Date : Dec . 13 , 2018 (54 ) HETEROLOGOUS UTR SEQUENCES FOR Publication Classification ENHANCED MRNA EXPRESSION (51 ) Int. Cl. A61K 48 / 00 ( 2006 .01 ) (71 ) Applicant : Moderna TX , Inc ., Cambridge , MA C12N 15 / 10 (2006 .01 ) (US ) C12N 15 /67 ( 2006 .01 ) (72 ) Inventors : David H . Burkhardt , Somerville , MA A61K 31 / 7115 ( 2006 .01 ) (US ) ; Romesh R . Subramanian , A61K 31 /712 ( 2006 .01 ) A61K 31 / 7125 (2006 . 01 ) Framingham , MA (US ) ; Christian A61P 1 / 16 ( 2006 .01 ) Cobaugh , Newton Highlands , MA (US ) A61P 31/ 14 (2006 .01 ) (52 ) U . S . CI. (73 ) Assignee : Moderna TX , Inc. , Cambridge , MA CPC . .. A61K 48 /0058 ( 2013 .01 ) ; C12N 15 / 1086 (US ) ( 2013 . 01 ) ; A61K 48 / 0066 ( 2013 .01 ) ; C12N 15 /67 ( 2013 .01 ) ; A61P 31 / 14 ( 2018 . 01 ) ; A61K ( 21 ) Appl . No . : 15 / 781, 827 31/ 712 (2013 .01 ) ; A61K 31/ 7125 ( 2013 .01 ) ; A61P 1 / 16 ( 2018 .01 ) ; A61K 31/ 7115 ( 22 ) PCT Filed : Dec . 9 , 2016 ( 2013 .01 ) ( 86 ) PCT No. : PCT/ US2016 / 065796 (57 ) ABSTRACT $ 371 ( c ) ( 1 ) , mRNAs containing an exogenous open reading frame (ORF ) ( 2 ) Date : flanked by a 5 ' untranslated region (UTR ) and a 3 ' UTR is Jun . 6 , 2018 provided , wherein the 5 ' and 3 ' UTRs are derived from a naturally abundant mRNA in a tissue . Also provided are Related U . S . Application Data methods for identifying the 5 ' and 3 ' UTRs, and methods for (60 ) Provisional application No . 62 / 265 , 233 , filed on Dec. making and using the mRNAs .
    [Show full text]
  • Expanding the Toolkit of Protein Engineering: Towards Multiple Simultaneous in Vivo Incorporation of Noncanonical Amino Acids
    TECHNISCHE UNIVERSITÄT MÜNCHEN Max-Planck-Institut für Biochemie Expanding the Toolkit of Protein Engineering: Towards Multiple Simultaneous In Vivo Incorporation of Noncanonical Amino Acids Michael G. Hösl Vollständiger Abdruck der von der Fakultät für Chemie der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. Michael Groll Prüfer der Dissertation: 1. Univ.-Prof. Dr. Nediljko Budisa, Technische Universität Berlin 2. Univ.-Prof. Dr. Thomas Kiefhaber 3. Univ.-Prof. Dr. Johannes Buchner Die Dissertation wurde am 01.02.11 bei der Technischen Universität München eingereicht und durch die Fakultät für Chemie am 03.03.11 angenommen. To Teresa Ariadna García-Grajalva Lucas who influenced the idea of TAG → AGG switch just by the existence of her name Sleeping is giving in, no matter what the time is. Sleeping is giving in, so lift those heavy eyelids. People say that you'll die faster than without water. But we know it's just a lie, scare your son, scare your daughter. People say that your dreams are the only things that save ya. Come on baby in our dreams, we can live on misbehavior. The Arcade Fire Parts of this work were published as listed below: Hoesl, MG, Budisa, N. Expanding and engineering the genetic code in a single expression experiment. ChemBioChem 2011, 12, 552-555. Further publications: Hoesl, MG*, Staudt, H*, Dreuw, A, Budisa, N, Grininger, M, Oesterhelt, D, Wachtveitl, J. Manipulating the eletron transfer in Dodecin by isostructual noncanonical Trp analogs. 2011, [in preparation]. *authors contributed equally to this work Nehring, S*, Hoesl, MG*, Acevedo-Rocha, CG*, Royter, M, Wolschner, C, Wiltschi, B, Budisa, N, Antranikian, G.
    [Show full text]
  • Broad and Adaptable RNA Structure Recognition by the Human Interferon-Induced Tetratricopeptide Repeat Protein IFIT5
    Broad and adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat protein IFIT5 George E. Katibaha, Yidan Qinb, David J. Sidoteb, Jun Yaob, Alan M. Lambowitzb,1, and Kathleen Collinsa,1 aDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; and bInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, University of Texas at Austin, Austin, TX 78712 Contributed by Alan M. Lambowitz, July 8, 2014 (sent for review April 29, 2014; reviewed by Sandra L. Wolin, Eric Phizicky, and Michael Gale, Jr.) Interferon (IFN) responses play key roles in cellular defense against copy numbers and combinations of four distinct IFIT proteins pathogens. Highly expressed IFN-induced proteins with tetratrico- (IFIT1, 2, 3, and 5) even within mammals, generated by paralog peptide repeats (IFITs) are proposed to function as RNA binding expansions and/or gene deletions, including the loss of IFIT5 in proteins, but the RNA binding and discrimination specificities of IFIT mice and rats (14). Human IFIT1, IFIT2, and IFIT3 coassemble proteins remain unclear. Here we show that human IFIT5 has in cells into poorly characterized multimeric complexes that ex- comparable affinity for RNAs with diverse phosphate-containing 5′- clude IFIT5 (15, 16). Recombinant IFIT family proteins range ends, excluding the higher eukaryotic mRNA cap. Systematic muta- from monomer to multimer, with crystal structures solved for genesis revealed that sequence substitutions in IFIT5 can alternatively a human IFIT2 homodimer (17), the human IFIT5 monomer expand or introduce bias in protein binding to RNAs with 5′ mono- (16, 18, 19), and an N-terminal fragment of human IFIT1 (18).
    [Show full text]
  • Genome-Wide Investigation of Cellular Functions for Trna Nucleus
    Genome-wide Investigation of Cellular Functions for tRNA Nucleus- Cytoplasm Trafficking in the Yeast Saccharomyces cerevisiae DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Hui-Yi Chu Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2012 Dissertation Committee: Anita K. Hopper, Advisor Stephen Osmani Kurt Fredrick Jane Jackman Copyright by Hui-Yi Chu 2012 Abstract In eukaryotic cells tRNAs are transcribed in the nucleus and exported to the cytoplasm for their essential role in protein synthesis. This export event was thought to be unidirectional. Surprisingly, several lines of evidence showed that mature cytoplasmic tRNAs shuttle between nucleus and cytoplasm and their distribution is nutrient-dependent. This newly discovered tRNA retrograde process is conserved from yeast to vertebrates. Although how exactly the tRNA nuclear-cytoplasmic trafficking is regulated is still under investigation, previous studies identified several transporters involved in tRNA subcellular dynamics. At least three members of the β-importin family function in tRNA nuclear-cytoplasmic intracellular movement: (1) Los1 functions in both the tRNA primary export and re-export processes; (2) Mtr10, directly or indirectly, is responsible for the constitutive retrograde import of cytoplasmic tRNA to the nucleus; (3) Msn5 functions solely in the re-export process. In this thesis I focus on the physiological role(s) of the tRNA nuclear retrograde pathway. One possibility is that nuclear accumulation of cytoplasmic tRNA serves to modulate translation of particular transcripts. To test this hypothesis, I compared expression profiles from non-translating mRNAs and polyribosome-bound translating mRNAs collected from msn5Δ and mtr10Δ mutants and wild-type cells, in fed or acute amino acid starvation conditions.
    [Show full text]
  • FUNCTIONAL and MECHANISTIC CHARACTERIZATION of TWO TRNA MODIFYING ENZYMES LAURA CAROLE KEFFER-WILKES Master of Science, Universi
    FUNCTIONAL AND MECHANISTIC CHARACTERIZATION OF TWO TRNA MODIFYING ENZYMES LAURA CAROLE KEFFER-WILKES Master of Science, University of Lethbridge, 2012 A Thesis Submitted to the School of Graduate Studies Of the University of Lethbridge In Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY Department of Chemistry and Biochemistry University of Lethbridge LETHBRIDGE, ALBERTA, CANADA © Laura Keffer-Wilkes, 2016 FUNCTIONAL AND MECHANISTIC CHARACTERIZATION OF TWO TRNA MODIFYING ENZYMES LAURA CAROLE KEFFER-WILKES Date of Defence: June 28, 2016 Dr. Ute Wieden-Kothe Associate Professor Ph.D. Supervisor Dr. Tony Russell Assistant Professor Ph.D. Thesis Examination Committee Member Dr. Stacey Wetmore Professor Ph.D. Thesis Examination Committee Member Dr. Hans-Joachim Wieden Professor Ph.D. Thesis Examination Committee Member Dr. Eugene Mueller Professor Ph.D. External Examiner University of Louisville Louisville, Kentucky Dr. Elizabeth Schultz Associate Professor Ph.D. Internal External Examiner University of Lethbridge Dr. Michael Gerken Professor Ph.D. Chair, Thesis Examination Committee Abstract The formation of pseudouridine (Ѱ) and 5-methyluridine (m5U) in the T-arm of transfer RNAs (tRNAs) is near-universally conserved. These two modifications are formed in Escherichia coli by the pseudouridine synthase TruB and the S-adenosylmethionine- dependent methyltransferase TrmA, respectively. In this thesis, I investigate the function and mechanisms of these two tRNA modifying enzymes. First, in vitro and in vivo analysis of TruB reveals that this enzyme is acting as a tRNA chaperone which proves a long outstanding hypothesis. Secondly, characterization of ligand binding by TrmA shows that binding is cooperative and disruption of tRNA elbow region tertiary interactions by TrmA is essential for efficient tRNA binding and catalysis, leading to future analysis.
    [Show full text]
  • From Trna Modifications to DNA Adducts and Back to Miscoding Ribonucleotides F
    Guengerich and Ghodke Genes and Environment (2021) 43:24 https://doi.org/10.1186/s41021-021-00199-x REVIEW Open Access Etheno adducts: from tRNA modifications to DNA adducts and back to miscoding ribonucleotides F. Peter Guengerich* and Pratibha P. Ghodke Abstract Etheno (and ethano) derivatives of nucleic acid bases have an extra 5-membered ring attached. These were first noted as wyosine bases in tRNAs. Some were fluorescent, and the development of etheno derivatives of adenosine, cytosine, and guanosine led to the synthesis of fluorescent analogs of ATP, NAD+, and other cofactors for use in biochemical studies. Early studies with the carcinogen vinyl chloride revealed that these modified bases were being formed in DNA and RNA and might be responsible for mutations and cancer. The etheno bases are also derived from other carcinogenic vinyl monomers. Further work showed that endogenous etheno DNA adducts were present in animals and humans and are derived from lipid peroxidation. The chemical mechanisms of etheno adduct formation involve reactions with bis-electrophiles generated by cytochrome P450 enzymes or lipid peroxidation, which have been established in isotopic labeling studies. The mechanisms by which etheno DNA adducts miscode have been studied with several DNA polymerases, aided by the X-ray crystal structures of these polymerases in mispairing situations and in extension beyond mispairs. Repair of etheno DNA adduct damage is done primarily by glycosylases and also by the direct action of dioxygenases. Some human DNA polymerases (η, κ) can insert bases opposite etheno adducts in DNA and RNA, and the reverse transcriptase activity may be of relevance with the RNA etheno adducts.
    [Show full text]
  • The Evolution and Functions of Trna Modifications
    life Review From Prebiotics to Probiotics: The Evolution and Functions of tRNA Modifications Katherine M. McKenney 1,2 and Juan D. Alfonzo 1,2,3,* 1 The Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA; [email protected] 2 The Ohio State Biochemistry Program, The Ohio State University, Columbus, OH 43210, USA 3 Department of Microbiology, The Ohio State University, Columbus, OH 43210, USA * Correspondence: [email protected]; Tel.: +1-614-292-0004 Academic Editors: Adrian Gabriel Torres and David Deamer Received: 11 January 2016; Accepted: 7 March 2016; Published: 14 March 2016 Abstract: All nucleic acids in cells are subject to post-transcriptional chemical modifications. These are catalyzed by a myriad of enzymes with exquisite specificity and that utilize an often-exotic array of chemical substrates. In no molecule are modifications more prevalent than in transfer RNAs. In the present document, we will attempt to take a chemical rollercoaster ride from prebiotic times to the present, with nucleoside modifications as key players and tRNA as the centerpiece that drove the evolution of biological systems to where we are today. These ideas will be put forth while touching on several examples of tRNA modification enzymes and their modus operandi in cells. In passing, we submit that the choice of tRNA is not a whimsical one but rather highlights its critical function as an essential invention for the evolution of protein enzymes. Keywords: tRNA modification; evolution; genetic code 1. Before There Was RNA, There Were Modifications Through the years there has been a seemingly limitless and constant supply of ideas and discussions about the origin of life; all envision numerous scenarios with the common theme that, based on modern day biological systems, replication and information storage were needed for a self-sustaining system to survive.
    [Show full text]
  • Using Pathway Covering to Explore Connections Among Metabolites
    H OH metabolites OH Article Using Pathway Covering to Explore Connections among Metabolites Peter E. Midford 1 , Mario Latendresse 1 , Paul E. O’Maille 2 and Peter D. Karp 1,* 1 Bioinformatics Research Group, SRI, International, Menlo Park, CA 94025, USA; [email protected] (P.E.M.); [email protected] (M.L.) 2 Biocomplexity Sciences, SRI International, Menlo Park, CA 94025, USA; [email protected] * Correspondence: [email protected] Received: 16 March 2019; Accepted: 26 April 2019; Published: 2 May 2019 Abstract: Interpreting changes in metabolite abundance in response to experimental treatments or disease states remains a major challenge in metabolomics. Pathway Covering is a new algorithm that takes a list of metabolites (compounds) and determines a minimum-cost set of metabolic pathways in an organism that includes (covers) all the metabolites in the list. We used five functions for assigning costs to pathways, including assigning a constant for all pathways, which yields a solution with the smallest pathway count; two methods that penalize large pathways; one that prefers pathways based on the pathway’s assigned function, and one that loosely corresponds to metabolic flux. The pathway covering set computed by the algorithm can be displayed as a multi-pathway diagram (“pathway collage”) that highlights the covered metabolites. We investigated the pathway covering algorithm by using several datasets from the Metabolomics Workbench. The algorithm is best applied to a list of metabolites with significant statistics and fold-changes with a specified direction of change for each metabolite. The pathway covering algorithm is now available within the Pathway Tools software and BioCyc website.
    [Show full text]
  • Processing, Modification and Anticodon–Codon
    biomolecules Review Factors That Shape Eukaryotic tRNAomes: Processing, Modification and Anticodon–Codon Use Richard J. Maraia 1,2,* and Aneeshkumar G. Arimbasseri 3,* 1 Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA 2 Commissioned Corps, U.S. Public Health Service, Rockville, MD 20016, USA 3 Molecular Genetics Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India * Correspondence: [email protected] (R.J.M.); [email protected] (A.G.A.) Academic Editor: Valérie de Crécy-Lagard Received: 9 January 2017; Accepted: 24 February 2017; Published: 8 March 2017 Abstract: Transfer RNAs (tRNAs) contain sequence diversity beyond their anticodons and the large variety of nucleotide modifications found in all kingdoms of life. Some modifications stabilize structure and fit in the ribosome whereas those to the anticodon loop modulate messenger RNA (mRNA) decoding activity more directly. The identities of tRNAs with some universal anticodon loop modifications vary among distant and parallel species, likely to accommodate fine tuning for their translation systems. This plasticity in positions 34 (wobble) and 37 is reflected in codon use bias. Here, we review convergent evidence that suggest that expansion of the eukaryotic tRNAome was supported by its dedicated RNA polymerase III transcription system and coupling to the precursor-tRNA chaperone, La protein. We also review aspects of eukaryotic tRNAome evolution involving G34/A34 anticodon-sparing, relation to A34 modification to inosine, biased codon use and regulatory information in the redundancy (synonymous) component of the genetic code. We then review interdependent anticodon loop modifications involving position 37 in 3 eukaryotes.
    [Show full text]
  • Origin and Evolution of Peptide-Modifying Dioxygenases and Identification of the Wybutosine Hydroxylase/Hydroperoxidase Lakshminarayan M
    Published online 27 April 2010 Nucleic Acids Research, 2010, Vol. 38, No. 16 5261–5279 doi:10.1093/nar/gkq265 Origin and evolution of peptide-modifying dioxygenases and identification of the wybutosine hydroxylase/hydroperoxidase Lakshminarayan M. Iyer, Saraswathi Abhiman, Robson F. de Souza and L. Aravind* National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA Received February 26, 2010; Revised March 26, 2010; Accepted March 30, 2010 ABSTRACT eukaryotic enzymes. The specificity of wybutosine Unlike classical 2-oxoglutarate and iron-dependent hydroxylase/peroxidase probably relates to the dioxygenases, which include several nucleic acid structural similarity of the modified moiety to the modifiers, the structurally similar jumonji-related ancestral amino acid substrate of this superfamily. dioxygenase superfamily was only known to catalyze peptide modifications. Using comparative INTRODUCTION genomics methods, we predict that a family of RNAs, especially transfer RNAs (tRNA), show diverse jumonji-related enzymes catalyzes wybutosine hy- post-translational modifications of bases. To date, at droxylation/peroxidation at position 37 of eukaryotic least 90 distinct modifications have been described (1,2). tRNAPhe. Identification of this enzyme raised ques- These include simple substitutions (e.g. deamination of tions regarding the emergence of protein- and adenosine to inosine), addition of small functional nucleic acid-modifying activities among jumonji- groups to bases (such as a methyl group in related domains. We addressed these with a 1-methylguanosine) and chemical transformations result- natural classification of DSBH domains and recon- ing in large complex bases (such as threonyl structed the precursor of the dioxygenases as a carbamoyladenosine, queuosine and wyosine and their further derivatives).
    [Show full text]
  • Synthesis of Natural Modified Nucleosides and Their Mass Spectrometric Quantification in Cells and Tissue
    Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Synthesis of natural modified nucleosides and their mass spectrometric quantification in cells and tissue Synthese von natürlichen modifizierten Nukleosiden und deren massenspektrometrische Quantifizierung in Zellen und Gewebe Daniel Globisch aus Kaiserslautern 2011 Erklärung Diese Dissertation wurde im Sinne von § 13 Abs. 3 bzw. 4 der Promotionsordnung der LMU München vom 29. Januar 1998 von Prof. Dr. T. Carell betreut. Ehrenwörtliche Versicherung Diese Dissertation wurde selbstständig, ohne unerlaubte Hilfe erarbeitet. München, den 02.02.2011 Daniel Globisch Dissertation eingereicht am: 03.02.2011 1. Gutachter: Prof. Dr. T. Carell 2. Gutachter: Prof. Dr. S. A. Sieber Mündliche Prüfung am: 11.03.2011 The Truth Is Out There Danksagung An erster Stelle danke ich meinem Betreuer Prof. Dr. Thomas Carell für die interessante Themenstellung, die exzellenten Arbeitsbedingungen und die große wissenschaftliche Freiheit. Seine Motivationsstärke, aufbauenden Ratschläge und Begeisterung für die Bioorganik haben entscheidend zum Erfolg dieser Arbeit und meinem Interesse an der Forschung beigetragen. Vielen Dank für die hervorragende Unterstützung während meiner gesamten Promotionszeit. Den Mitgliedern der Prüfungskommission danke ich für ihre Bemühungen und den zeitlichen Aufwand bei der Evaluierung der Arbeit. Prof. Dr. Stephan A. Sieber danke ich recht herzlich für die Übernahme des Koreferats. Darüberhinaus bin ich ihm für die Hilfe bei allen massenspektrometrischen Fragestellungen zu großem Dank verpflichtet, wobei sich neben anregenden Diskussionen auch eine hervorragende und unkomplizierte Kooperation ergab. Prof. Dr. Martin Biel danke ich für die erfolgreiche Kooperation. Frau Slava Gärtner und Frau Sabine Voß danke ich für die hervorragende Hilfsbereitschaft bei allen bürokratischen und organisatorischen Fragen.
    [Show full text]
  • United States Patent ( 10 ) Patent No.: US 10,653,712 B2 Hoge Et Al
    US010653712B2 United States Patent ( 10 ) Patent No.: US 10,653,712 B2 Hoge et al. (45 ) Date of Patent : May 19 , 2020 (54 ) HIGH PURITY RNA COMPOSITIONS AND 6,528,262 B1 3/2003 Gilad et al. METHODS FOR PREPARATION THEREOF 8,383,340 B2 2/2013 Ketterer et al. 8,710,200 B2 4/2014 Schrum et al . 8,754,062 B2 6/2014 De Fougerolles et al. (71 ) Applicant: Moderna TX , Inc., Cambridge, MA 8,822,663 B2 9/2014 Schrum et al. (US ) 8,999,380 B2 4/2015 Bancel et al. 9,221,891 B2 12/2015 Bancel et al . (72 ) Inventors : Stephen Hoge , Brookline , MA (US ) ; 9,303,079 B2 4/2016 Bancel et al. 9,464,124 B2 10/2016 Bancel et al. William Issa , Dedham , MA (US ) ; 9,512,456 B2 12/2016 Wang et al. Edward J. Miracco , Arlington , MA 9,597,380 B2 3/2017 Chakraborty et al . (US ) ; Jennifer Nelson , Brookline, MA 9,868,691 B2 1/2018 Benenato et al. (US ) ; Amy E. Rabideau , Waltham , MA 9,872,900 B2 1/2018 Ciaramella et al. 10,064,934 B2 9/2018 Ciaramella et al . (US ) ; Gabor Butora , Martinsville , NJ 10,064,935 B2 9/2018 Ciaramella et al . (US ) 10,124,055 B2 11/2018 Ciaramella et al . 10,207,010 B2 2/2019 Besin et al. ( 73 ) Assignee : ModernaTX , Inc., Cambridge , MA 10,273,269 B2 4/2019 Ciaramella (US ) 2001/0001066 Al 5/2001 Cezayirli et al . 2001/0005506 A1 6/2001 Cezayirli et al . Subject to any disclaimer , the term of this 2006/0247195 A1 11/2006 Ray ( * ) Notice : 2007/0281336 A1 12/2007 Jendrisak et al .
    [Show full text]